833 related articles for article (PubMed ID: 29427925)
1. Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery.
Yu L; Chen Y; Lin H; Du W; Chen H; Shi J
Biomaterials; 2018 Apr; 161():292-305. PubMed ID: 29427925
[TBL] [Abstract][Full Text] [Related]
2. A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy.
Yue J; Luo SZ; Lu MM; Shao D; Wang Z; Dong WF
Chem Biol Drug Des; 2018 Aug; 92(2):1435-1444. PubMed ID: 29671941
[TBL] [Abstract][Full Text] [Related]
3. Controllable synthesis of versatile mesoporous organosilica nanoparticles as precision cancer theranostics.
Cheng Y; Jiao X; Fan W; Yang Z; Wen Y; Chen X
Biomaterials; 2020 Oct; 256():120191. PubMed ID: 32593907
[TBL] [Abstract][Full Text] [Related]
4. Molecularly organic/inorganic hybrid hollow mesoporous organosilica nanocapsules with tumor-specific biodegradability and enhanced chemotherapeutic functionality.
Huang P; Chen Y; Lin H; Yu L; Zhang L; Wang L; Zhu Y; Shi J
Biomaterials; 2017 May; 125():23-37. PubMed ID: 28226244
[TBL] [Abstract][Full Text] [Related]
5. "Manganese Extraction" Strategy Enables Tumor-Sensitive Biodegradability and Theranostics of Nanoparticles.
Yu L; Chen Y; Wu M; Cai X; Yao H; Zhang L; Chen H; Shi J
J Am Chem Soc; 2016 Aug; 138(31):9881-94. PubMed ID: 27441571
[TBL] [Abstract][Full Text] [Related]
6. Coordination-Accelerated "Iron Extraction" Enables Fast Biodegradation of Mesoporous Silica-Based Hollow Nanoparticles.
Wang L; Huo M; Chen Y; Shi J
Adv Healthc Mater; 2017 Nov; 6(22):. PubMed ID: 28941142
[TBL] [Abstract][Full Text] [Related]
7. Core-shell hierarchical mesostructured silica nanoparticles for gene/chemo-synergetic stepwise therapy of multidrug-resistant cancer.
Sun L; Wang D; Chen Y; Wang L; Huang P; Li Y; Liu Z; Yao H; Shi J
Biomaterials; 2017 Jul; 133():219-228. PubMed ID: 28441616
[TBL] [Abstract][Full Text] [Related]
8. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery.
Du X; Li X; Xiong L; Zhang X; Kleitz F; Qiao SZ
Biomaterials; 2016 Jun; 91():90-127. PubMed ID: 27017579
[TBL] [Abstract][Full Text] [Related]
9. Facile synthesis of organosilica-capped mesoporous silica nanocarriers with selective redox-triggered drug release properties for safe tumor chemotherapy.
Shen L; Pan S; Niu D; He J; Jia X; Hao J; Gu J; Zhao W; Li P; Li Y
Biomater Sci; 2019 Apr; 7(5):1825-1832. PubMed ID: 30892297
[TBL] [Abstract][Full Text] [Related]
10. Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications.
Croissant JG; Fatieiev Y; Almalik A; Khashab NM
Adv Healthc Mater; 2018 Feb; 7(4):. PubMed ID: 29193848
[TBL] [Abstract][Full Text] [Related]
11. Tumor Acidic Microenvironment Targeted Drug Delivery Based on pHLIP-Modified Mesoporous Organosilica Nanoparticles.
Zhang Y; Dang M; Tian Y; Zhu Y; Liu W; Tian W; Su Y; Ni Q; Xu C; Lu N; Tao J; Li Y; Zhao S; Zhao Y; Yang Z; Sun L; Teng Z; Lu G
ACS Appl Mater Interfaces; 2017 Sep; 9(36):30543-30552. PubMed ID: 28809111
[TBL] [Abstract][Full Text] [Related]
12. Chemistry of Mesoporous Organosilica in Nanotechnology: Molecularly Organic-Inorganic Hybridization into Frameworks.
Chen Y; Shi J
Adv Mater; 2016 May; 28(17):3235-72. PubMed ID: 26936391
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
[TBL] [Abstract][Full Text] [Related]
14. Biomimetic Diselenide-Bridged Mesoporous Organosilica Nanoparticles as an X-ray-Responsive Biodegradable Carrier for Chemo-Immunotherapy.
Shao D; Zhang F; Chen F; Zheng X; Hu H; Yang C; Tu Z; Wang Z; Chang Z; Lu J; Li T; Zhang Y; Chen L; Leong KW; Dong WF
Adv Mater; 2020 Dec; 32(50):e2004385. PubMed ID: 33164250
[TBL] [Abstract][Full Text] [Related]
15. Nanoscale Metal-Organic-Frameworks Coated by Biodegradable Organosilica for pH and Redox Dual Responsive Drug Release and High-Performance Anticancer Therapy.
Ren SZ; Zhu D; Zhu XH; Wang B; Yang YS; Sun WX; Wang XM; Lv PC; Wang ZC; Zhu HL
ACS Appl Mater Interfaces; 2019 Jun; 11(23):20678-20688. PubMed ID: 31081332
[TBL] [Abstract][Full Text] [Related]
16. Functionalization of mesoporous organosilica nanocarrier for pH/glutathione dual-responsive drug delivery and imaging of cancer therapy process.
Hu LL; Meng J; Zhang DD; Chen ML; Shu Y; Wang JH
Talanta; 2018 Jan; 177():203-211. PubMed ID: 29108577
[TBL] [Abstract][Full Text] [Related]
17. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
[TBL] [Abstract][Full Text] [Related]
18. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
[TBL] [Abstract][Full Text] [Related]
19. Hollow mesoporous organosilica nanoparticles: a generic intelligent framework-hybridization approach for biomedicine.
Chen Y; Meng Q; Wu M; Wang S; Xu P; Chen H; Li Y; Zhang L; Wang L; Shi J
J Am Chem Soc; 2014 Nov; 136(46):16326-34. PubMed ID: 25343459
[TBL] [Abstract][Full Text] [Related]
20. Dual gatekeepers-modified mesoporous organic silica nanoparticles for synergistic photothermal-chemotherapy of breast cancer.
Wang W; Zhong F; Wang D; Zhao Y; Peng D; Li S; Ning Q; Tang S; Yu CY; Wei H
J Colloid Interface Sci; 2023 Sep; 646():118-128. PubMed ID: 37187045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
